American International Group, Inc. Durect Corp Transaction History

American International Group, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.38 - $0.64 $42,680 - $71,882	-112,316 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.55 - $0.98 $4,348 - $7,747	-7,906 Reduced 6.58%	112,316 $75,000
Q4 2021 Feb 11, 2022	SELL	$0.9 - $1.31 $3,237 - $4,712	-3,597 Reduced 2.91%	120,222 $119,000
Q3 2021 Nov 12, 2021	SELL	$1.21 - $1.61 $3,559 - $4,736	-2,942 Reduced 2.32%	123,819 $158,000
Q2 2021 Aug 13, 2021	SELL	$1.6 - $2.02 $5,142 - $6,492	-3,214 Reduced 2.47%	126,761 $207,000
Q1 2021 May 07, 2021	BUY	$1.86 - $2.87 $19,965 - $30,806	10,734 Added 9.0%	129,975 $257,000
Q4 2020 Feb 12, 2021	SELL	$1.65 - $2.43 $3,052 - $4,495	-1,850 Reduced 1.53%	119,241 $247,000
Q3 2020 Nov 04, 2020	BUY	$1.6 - $2.35 $214 - $314	134 Added 0.11%	121,091 $207,000
Q2 2020 Aug 12, 2020	BUY	$1.33 - $2.76 $160,872 - $333,841	120,957 New	120,957 $281,000
Q2 2019 Aug 13, 2019	SELL	$0.51 - $0.86 $50,977 - $85,961	-99,955 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$0.51 - $0.82 $1,651 - $2,655	-3,239 Reduced 3.14%	99,955 $63,000
Q4 2018 Feb 13, 2019	SELL	$0.48 - $1.1 $381 - $873	-794 Reduced 0.76%	103,194 $50,000
Q3 2018 Nov 09, 2018	BUY	$1.06 - $1.69 $1,987 - $3,168	1,875 Added 1.84%	103,988 $114,000
Q2 2018 Aug 08, 2018	BUY	$1.56 - $2.51 $16,233 - $26,119	10,406 Added 11.35%	102,113 $159,000
Q1 2018 May 07, 2018	SELL	$0.91 - $2.24 $4,488 - $11,047	-4,932 Reduced 5.1%	91,707 $196,000
Q4 2017 Feb 09, 2018	BUY	$0.78 - $2.1 $3,678 - $9,903	4,716 Added 5.13%	96,639 $89,000
Q3 2017 Nov 09, 2017	BUY	$1.55 - $1.82 $142,480 - $167,299	91,923	91,923 $163,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $214M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.